Safety of Zofran and Pepcid During Breastfeeding
Both Zofran (ondansetron) and Pepcid (famotidine) can be used while breastfeeding, though the evidence is stronger for famotidine than ondansetron.
Ondansetron (Zofran)
The 2020 Association of Anaesthetists guideline states that while there are no human studies on ondansetron transfer into breast milk, only animal data exist 1. Despite this limitation, the guideline does not contraindicate its use during breastfeeding. The FDA label similarly notes that "it is not known whether ondansetron is excreted in human milk" and recommends that "caution should be exercised when ondansetron is administered to a nursing woman" 2.
The lack of human data means ondansetron should be used with informed caution during breastfeeding, but it is not contraindicated. Given that ondansetron is commonly used for nausea and vomiting in pregnancy and postoperative settings, and considering its pharmacologic properties, the risk to the breastfed infant appears low, though not definitively established.
Famotidine (Pepcid)
Famotidine has more favorable evidence for breastfeeding safety. A 1998 review specifically identified that famotidine is excreted into breast milk to a lesser extent than cimetidine or ranitidine and may be the preferred histamine antagonist during lactation 3. This makes famotidine a better choice among H2-receptor antagonists for breastfeeding mothers.
Clinical Approach
- For acid suppression needs: Famotidine is preferred among H2-blockers due to lower milk transfer 3
- For nausea/vomiting: Ondansetron can be used, though alternatives with more established lactation data (such as metoclopramide or promethazine) may be considered first depending on clinical context 1
- General principle: The AAP guideline emphasizes that most maternal medications are compatible with breastfeeding, and the comprehensive Drugs and Lactation Database (LactMed) should be consulted for detailed information 4, 5
Important Caveats
- Monitor the infant for any unusual symptoms (drowsiness, feeding changes, irritability)
- The benefits of continued breastfeeding typically outweigh theoretical medication risks for most drugs 5
- Unnecessary cessation of breastfeeding can lead to mastitis, decreased milk supply, and loss of breastfeeding benefits 6
- When multiple medication options exist, choose those with the most established safety data during lactation